The First Crispr Treatment Is Making Its Way to Patients
It’s been a year since the gene-editing treatment Casgevy was approved for sickle cell disease and a related blood disorder.
New Scientist16h
Weight-loss medications may also ease chronic pain
Popular semaglutide-based drugs used for weight loss may reduce chronic and acute pain, which could make them a promising ...
Hosted on MSN2d
What is gabapentin? Here's why it's so controversial.
Dr. Holly Geyer, an addiction medicine specialist and the lead physician ... treat seizures and to diminish a specific type of nerve pain called post-herpetic neuralgia that often follows a shingles' ...
Pharmacist warns life-altering condition could be lying ‘dormant’ in a third of adults
Many Brits might unknowingly be walking a knife’s edge with their health, as an expert warned if left untreated, the disease ...
Pharmacist's red flag warning on 'dormant' serious health condition affecting one in three adults
Many Brits could be unknowingly teetering on the brink of serious health issues, as a leading expert warns that if left ...